ME
23andMe Holding Co.
Chief Therapeutics Officer Kenneth J. Hillan sold $32K of 23andMe Holding Co.
Sold$31,861
$3.64Price
8,753Shares
−4%Stake
What ME did after the filing
Prices for ME after this filing aren't in yet.
Traded Wed, Aug 24. Filed Thu, Aug 25, 1:00 PM ET, during the session. Not investment advice.